CI
TAK icon

Cordant Inc’s Takeda Pharmaceutical TAK Stock Holding History

Cordant Inc’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-226
Closed -$4K – 63
2020
Q3 		$4K Buy
+226
New +$4.12K ﹤0.01% 53
2020
Q1 		– Sell
-220
Closed -$4K – 171
2019
Q4 		$4K Buy
+220
New +$4.21K ﹤0.01% 135

Other funds holding TAK

GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
AC
Adelphi Capital London, United Kingdom $3.21M AUM 121.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM

Cordant Inc's TAK Position: Q4 2020 in Review

Cordant Inc sold out of Takeda Pharmaceutical (TAK) in Q4 2020, closing a stake of 226 shares — an estimated $4K sold.

Cordant Inc first reported a position in TAK in Q4 2019 and held it in 2 quarters. The position peaked at $4K in Q3 2020. 313 funds tracked by Wall St. Rank hold TAK as of Q4 2020.

  • Cordant Inc reported no remaining Takeda Pharmaceutical position as of Q4 2020 after selling out during the quarter.
  • Cordant Inc sold 226 Takeda Pharmaceutical shares in Q4 2020, an estimated $4K.
  • Cordant Inc first reported a position in Takeda Pharmaceutical in Q4 2019 and held it in 2 quarters.
  • Cordant Inc's Takeda Pharmaceutical position peaked at $4K in Q3 2020.
  • 313 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2020.

Based on Cordant Inc's 13F filing for Q4 2020, filed 27 Jan 2021.